Differential effects of intravenous R,S-(±)-3,4- methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core

Journal of Neurochemistry

Volumn 102, Issue 1, 2007, Pages 121-132

  Acquas, Elio ^a   Pisanu, Augusta ^a   Spiga, Saturnino ^a   Plumitallo, Antonio ^a   Zernig, Gerald ^b   Chiara, Gaetano Di ^a,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c CNR   (Italy)

Author keywords

Accumbens shell; Dopamine; Microdialysis; Phosphorylated extracellular signal regulated kinase; R,S( ) methylenedioxymethamphetamine (Ecstasy); Stereoselectivity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; ECOPIPAM; MITOGEN ACTIVATED PROTEIN KINASE; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; DIALYSATE; DOPAMINERGIC TRANSMISSION; ENANTIOMER; ENZYME PHOSPHORYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; MICRODIALYSIS; MONITORING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY; VEIN CATHETERIZATION;

ANIMALS; DOPAMINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HALLUCINOGENS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 34250171237     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04451.x     Document Type: Article

References (49)

1. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A. Di Chiara G. (2001) Intravenous administration of ecstasy (3,4- methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur. J. Pharmacol. 418, 207 211.
2. Atkins C. M., Selcher J. C., Petraitis J. J., Trzaskos J. M. Sweatt J. D. (1998) The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1, 602 609.
3. Berhow M. T., Hiroi N. Nestler E. J. (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707 4715.
4. Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E. Di Chiara G. (2005) Effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine transmission in the nucleus accumbens shell and core. Brain Res. 1055, 143 148.
5. Colado M. I., O'Shea E. Green A. R. (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173, 249 263.
6. Crane A. M. Porrino L. J. (1989) Adaptation of the quantitative 2-[14C]-deoxyglucose method for use in freely moving rats. Brain Res. 499, 87 92.
7. Daniela E., Brennan K., Gittings D., Hely L. Schenk S. (2004) Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol. Biochem. Behav. 77, 745 750.
8. Di Chiara G. (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375, 13 30.
9. Di Chiara G. (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Eur. J. Pharmacol. 137, 75 114.
10. Di Chiara G., Tanda G., Frau R. Carboni E. (1993) On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology 112, 398 402.
11. Dragunow M., Robertson G. S., Faull R. L., Robertson H. A. Jansen K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37, 287 294.
12. Fantegrossi W. E., Ullrich T., Rice K. C., Woods J. H. Winger G. (2002) 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 161, 356 364.
13. Fienberg A. A., Hiroi N., Mermelstein P. G. et al. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838 842.
14. Gifford A. N., Minabe Y., Toor A., Wang R. Y. Ashby C. R. Jr. (1996) Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons. Synapse 23, 52 57.
15. Gudelsky G. A. Nash J. F. (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66, 243 249.
16. Gudelsky G. A., Yamamoto B. K. Nash J. F. (1994) Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. Eur. J. Pharmacol. 264, 325 330.
17. Hiramatsu M. Cho A. K. (1990) Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology 29, 269 275.
18. Johnson M. P., Hoffman A. J. Nichols D. E. (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132, 269 276.
19. Kelland M. D., Freeman A. S. Chiodo L. A. (1989) (+/-)-3,4- Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Eur. J. Pharmacol. 169, 11 21.
20. Konradi C., Cole R. L., Heckers S. Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 5623 5634.
21. Lecca D., Cacciapaglia F., Valentini V., Gronli J., Spiga S. Di Chiara G. (2006a) Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology 184, 435 446.
22. Lecca D., Cacciapaglia F., Valentini V., Acquas E. Di Chiara G. (2006b) Differential neurochemical and behavioral adaptation to cocaine after response contingent and non-contingent exposure in the rat. Psychopharmacology, Epub ahead of print.
23. Matthews R. T., Champney T. H. Frye G. D. (1989) Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Pharmacol. Biochem. Behav. 33, 741 747.
24. McQuade R. D., Duffy R. A., Anderson C. C., Crosby G., Coffin V. L., Chipkin R. E. Barnett A. (1991) [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses. J Neurochem. 57, 2001 2010.
25. Mechan A. O., Esteban B., O'Shea E., Elliott J. M., Colado M. I. Green A. R. (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br. J. Pharmacol. 135, 170 180.
26. Morelli M., Carboni E., Cozzolino A., Tanda G. L., Pinna A. Di Chiara G. (1992) Combined microdialysis and fos immunohistochemistry for the estimation of dopamine neurotransmission in the rat caudate-putamen. J. Neurochem. 59, 1158 1160.
27. Paxinos G. Watson C. (1998) The rat brain in stereotaxic coordinates. Academic Press, Sydney.
28. Pontieri F. E., Tanda G. Di Chiara G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc. Natl Acad. Sci. USA 92, 12 304 12 308.
29. Pontieri F. E., Tanda G., Orzi F. Di Chiara G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255 257.
30. Ratzenboeck E., Saria A., Kriechbaum N. Zernig G. (2001) Reinforcing effects of MDMA ('ecstasy') in drug-naive and cocaine-trained rats. Pharmacology 62, 138 144.
31. Robertson G. S., Vincent S. R. Fibiger H. C. (1992) D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49, 285 296.
32. Sabol K. E. Seiden L. S. (1998) Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Res. 806, 69 78.
33. Salzmann J., Marie-Claire C., Le Guen S., Roques B. P. Noble F. (2003) Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br. J. Pharmacol. 140, 831 828.
34. Schafe G. E., Atkins C. M., Swank M. W., Bauer E. P., Sweatt J. D. LeDoux J. E. (2000) Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 20, 8177 8187.
35. Schenk S., Gittings D., Johnstone M. Daniela E. (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169, 21 27.
36. Schmidt C. J. (1987) Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur. J. Pharmacol. 136, 81 88.
37. Schmidt C. J., Levin J. A. Lovenberg W. (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36, 747 755.
38. Sgambato V., Pages C., Rogard M., Besson M. J. Caboche J. (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814 8825.
39. Shankaran M. Gudelsky G. A. (1998) Effect of 3,4- methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacol. Biochem. Behav. 61, 361 366.
40. Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 1 10.
41. Sweatt J. D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311 317.
42. Tanda G., Pontieri F. E. Di Chiara G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048 2050.
43. Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R. Caboche J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701 8709.
44. Valjent E., Pages C., Rogard M., Besson M. J., Maldonado R. Caboche J. (2001a) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342 352.
45. Valjent E., Caboche J. Vanhoutte P. (2001b) Mitogen-activated protein kinase/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory? Mol. Neurobiol. 23, 83 99.
46. Valjent E., Pages C., Herve D., Girault J. A. Caboche J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain, Eur. J. Neurosci. 19, 1826 1836.
47. Wakonigg G., Sturm K., Saria A. Zernig G. (2003) Methylenedioxymethamphetamine (MDMA, 'ecstasy') serves as a robust positive reinforcer in a rat runway procedure. Pharmacology 69, 180 182.
48. Yamamoto B. K. Spanos L. J. (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol. 148, 195 203.
49. Ying S. W., Futter M., Rosenblum K., Webber M. J., Hunt S. P., Bliss T. V. Bramham C. R. (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 22, 1532 1540.